Article Details

4D Molecular Therapeutics Announces Rare Disease Ophthalmology Product Candidate Portfolio ...

Retrieved on: 2021-06-24 10:52:30

Tags for this article:

Click the tags to see associated articles and topics

4D Molecular Therapeutics Announces Rare Disease Ophthalmology Product Candidate Portfolio .... View article details on hiswai:

Excerpt

Roche requested that 4DMT conclude the Roche-funded 4D-110 trial in advanced choroideremia patients as a result of Roche's assessment of a ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up